Ustekinumab

Introduction: What is Ustekinumab?

Ustekinumab is a biologic medication primarily used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. It is a monoclonal antibody that targets specific proteins in the immune system, helping to reduce inflammation and manage symptoms associated with these chronic conditions. Approved by the FDA in 2009, Ustekinumab has become a vital option for patients seeking relief from the debilitating effects of these diseases.

Uses of Ustekinumab

Ustekinumab is approved for several medical uses, including:

• Plaque Psoriasis: Ustekinumab is used to treat moderate to severe plaque psoriasis in adults and children aged 12 and older who are candidates for phototherapy or systemic therapy. It helps clear the skin and reduce the severity of the disease.
• Psoriatic Arthritis: This medication is indicated for adults 18 years and older with active psoriatic arthritis, either alone or in combination with other treatments, to help alleviate joint pain and swelling.
• Crohn's Disease: Ustekinumab is also approved for treating moderate to severe Crohn's disease in adults who have not responded well to other therapies. It helps reduce inflammation in the digestive tract.
• Ulcerative Colitis: Ustekinumab is approved for treating moderately to severely active ulcerative colitis in adults.

How Does It Work?

Ustekinumab works by targeting and inhibiting specific proteins in the immune system known as "interleukin-12 (IL-12) and interleukin-23 (IL-23). These proteins play a crucial role in the inflammatory process that leads to the symptoms of autoimmune diseases. By blocking these proteins, Ustekinumab helps to reduce inflammation, decrease the immune response, and ultimately improve the symptoms associated with conditions like psoriasis and Crohn's disease.

Dosage and Administration

Ustekinumab is administered via injection. The standard dosage for adults varies based on the condition being treated:

• Plaque Psoriasis: The initial dose is weight-based: 45 mg (?100 kg) or 90 mg (>100 kg), followed by a second dose after 4 weeks. Maintenance doses are given every 12 weeks.
• Psoriatic Arthritis: The initial dose is weight-based: 45 mg (?100 kg) or 90 mg (>100 kg), with a second dose after 4 weeks. Maintenance doses are also given every 12 weeks.
• Crohn's Disease: Single intravenous (IV) induction dose of 260 mg, followed by subcutaneous (SC) 90 mg at week 8, then every 8 weeks.

For pediatric patients (psoriasis only, ?6 years), the dosage is weight-based SC and should be determined by a healthcare provider.

Side Effects of Ustekinumab

Like all medications, Ustekinumab can cause side effects. Common side effects include:

• Injection site reactions (redness, swelling, pain)
• Headache
• Fatigue
• Nausea

Serious side effects may include:

• Increased risk of infections (due to immune suppression)
• Allergic reactions (rash, itching, swelling)
• Liver problems (elevated liver enzymes)
• Rare reports of malignancies (monitor long-term)
• Reversible posterior leukoencephalopathy syndrome (RPLS)

Patients should report any unusual symptoms to their healthcare provider promptly.

Drug Interactions

Ustekinumab may interact with other medications, which can affect its efficacy or increase the risk of side effects. Major drug interactions include:

• Immunosuppressants: Combining Ustekinumab with other immunosuppressive drugs may increase the risk of infections.
• Live Vaccines: Patients should avoid live vaccines while on Ustekinumab, as the immune response may be weakened.

Always inform your healthcare provider about all the medications and supplements you are taking.

Benefits of Ustekinumab

Ustekinumab offers several clinical and practical advantages:

• Targeted Therapy: It specifically targets the underlying causes of autoimmune diseases, leading to more effective symptom management.
• Long-lasting Effects: Many patients experience prolonged relief from symptoms, reducing the frequency of injections.
• Improved Quality of Life: By managing symptoms effectively, Ustekinumab can significantly enhance the quality of life for patients with chronic conditions.

Contraindications of Ustekinumab

Certain individuals should avoid using Ustekinumab, including:

• Pregnant or Breastfeeding Women: The effects on fetal development are not fully understood, so it is generally advised to avoid this medication during pregnancy and breastfeeding.
• Severe Infections: Patients with active infections should not use Ustekinumab until the infection is resolved.
• Hypersensitivity: Individuals with a known hypersensitivity to ustekinumab or its excipients should not take this medication.

Precautions and Warnings

Before starting Ustekinumab, patients should undergo specific lab tests to assess their overall health, including:

• Tuberculosis (TB) Screening: Patients should be tested for latent TB or other infections before starting treatment, as Ustekinumab can increase the risk of reactivation.
• Hepatitis B Virus (HBV) Screening: Test for HBV due to risk of reactivation.
• Liver Function Tests: Regular monitoring of liver enzymes is recommended to detect any potential liver issues early.

Patients should also be aware of the signs of infection and report any symptoms such as fever, chills, or persistent cough to their healthcare provider.

FAQs

• What is Ustekinumab used for? Ustekinumab is used to treat moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
• How is Ustekinumab administered? Ustekinumab is given as a subcutaneous injection (SC for most; IV induction for IBD only).
• What are the common side effects? Common side effects include injection site reactions, headache, fatigue, and nausea.
• Can I take Ustekinumab if I am pregnant? It is generally advised to avoid Ustekinumab during pregnancy due to potential risks to the fetus.
• How often do I need to take Ustekinumab? The frequency varies by condition: every 12 weeks (psoriasis/PsA) or 8 weeks (IBD) after initial doses.
• Are there any serious side effects? Yes, serious side effects can include increased risk of infections and allergic reactions.
• Can I receive vaccines while on Ustekinumab? Live vaccines should be avoided while taking Ustekinumab, as the immune response may be weakened.
• How does Ustekinumab work? Ustekinumab works by blocking specific proteins in the immune system that contribute to inflammation.
• What should I do if I miss a dose? If you miss a dose, contact your healthcare provider for guidance on when to take it.
• Is Ustekinumab effective for everyone? While many patients experience significant improvement, individual responses can vary. Consult your doctor for personalized advice.

Brand Names

Ustekinumab is marketed under several brand names, including:

• Stelara
• Wezlana (biosimilar)

Conclusion

Ustekinumab is a powerful medication that plays a crucial role in managing autoimmune diseases like psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. By targeting specific proteins in the immune system, it helps reduce inflammation and improve patients' quality of life. While it offers many benefits, it is essential to be aware of potential side effects and contraindications. Always consult your healthcare provider for personalized advice and treatment options.